Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre- and 10 post-intervention patient encounters for each urologist with an accrual target of 200 unique patient visits (100 pre and 100 post-intervention) over a half-year period. Patient encounters pre- and post-intervention will be audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation. Patients and urologists will complete additional surveys on their perceptions of patient-provider communication. Urologists will further describe their experience and rate their satisfaction with visual decision support. Communication (content and perceived) will be compared pre- and post-intervention with secondary comparisons by race and care setting. It was hypothesized that the discussion of risks and benefits of cancer surgery will increase post-intervention and that the strength of recommendation and perceptions of patient-provider communication will change. The secondary hypothesis is that these changes will differ by patient race and care setting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.

• Verbal informed consent was obtained to participate in the study.

• Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.

• Age ≥ 18 years at the time of consent.

• For patient subjects, HIPAA authorization for the release of personal health information and a new histologic diagnosis of localized prostate cancer based on prostate biopsy or clinical diagnosis of T1 renal mass (≤7 cm in diameter) Suspicion for kidney cancer based on cross-sectional imaging. New diagnosis is defined as within 6 months of consent. T1 renal masses include solid masses or Bosniak III/IV cystic masses.

• For physician subjects, practicing urologist in North Carolina at UNC Health, Novant Health, or an affiliated site and sees patients with suspected or confirmed prostate or kidney cancer.

Locations
United States
North Carolina
UNC Lineberger Comprehensive Cancer Center
RECRUITING
Chapel Hill
New Hanover Regional Medical Center
NOT_YET_RECRUITING
Wilmington
Contact Information
Primary
Deborah Usinger
dusinger@unc.edu
(919) 962-5431
Backup
Taylor Greene
taylor_greene@med.unc.edu
Time Frame
Start Date: 2025-04-24
Estimated Completion Date: 2025-11-30
Participants
Target number of participants: 220
Treatments
Experimental: Patient participants
Patient participants will complete a 10-minute baseline survey, 15-minute after-visit survey and 5-minute 6-month survey.
Experimental: Physician participants
Physician participants seeing patients with newly diagnosed localized prostate cancer and clinical T1 renal masses suspicious for kidney cancer.
Sponsors
Leads: UNC Lineberger Comprehensive Cancer Center

This content was sourced from clinicaltrials.gov